Abstract
It is estimated that approximately 1.3 million new cases of cancer will occur in the United States in 1997 (785,800 males, 596,600 females) [1]. Given a conservative estimate that 5% of these cases are hereditary, at least 65,000 patients will merit DNA testing annually. Using this same 5% estimate, then of the 181,600 cases of carcinoma of the breast and the 26,800 cases of carcinoma of the ovary that will occur in the United States during this same year, approximately 9080 patients with breast cancer and 1340 patients with ovarian carcinoma will fit a hereditary etiology. Barring new germline mutations, this means that each individual will be a member of a cancer-prone family. When viewed as annual incidence rates of hereditary cancer, it is clear that the prevalence of hereditary breast and ovarian carcinoma in the United States will truly be enormous. Similar calculations can be made for virtually all forms of cancer that will strike women.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics, 1997. CA Cancer J Clin 47:5–27.
Lynch HT, Foillett KL, Lynch PM, Albano WA, Mailliard JL, Pierson RL (1979) Family history in an oncology clinic: Implications for cancer genetics. JAMA 242:1268–1272.
David KL, Steiner-Grossman P (1991) The potential use of tumor registry data in the recognition and prevention of hereditary and familial cancer. N Y State J Med 91:150–152.
Arvanitis ML, Jagelman DG, Fazio VN, Lavery IC, McGannon E (1990) Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 33:639–642.
Lynch HT, Mulcahy GM, Harris RE, Guirgis HA, Lynch JF (1978) Genetic and pathologic findings in a kindred with hereditary sarcoma breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma. Cancer 41:2055–2064.
Lynch HT, Radford B, Lynch JF (1990) SBLA syndrome revisited. Oncology 47:75–79.
Hartley AL, Birch JM, Kelsey AM, Marsden HB, Harris M, Teare MD (1989) Are germ cell tumors part of the Li-Fraumeni cancer family syndrome?. Cancer Genet Cytogenet 42:221–226.
Malkin D, Li FP, Stron LC, Fraumeni JF Jr., Nelson CE, Kim DH, Kassel J, Gryka MA, Mischoff FZ, Tainsky MA, et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250:1233–1238.
Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lenoir GM (1991) Familial breast-ovarian cancer locus on chromosome 17q12-923. Lancet 388:82–83.
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averiii D, et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:1088–2090.
Miki Y, Swensen J, Shattuck-Eidens D, et al. (1994) Isolation of BRCA1, the 17q-linked breast and ovarian susceptibility gene. Science 266:66–71.
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792.
Spirio L, Olschwang S, Groden J, Robertson M, Samowitz W, Joslyn G, et al. (1993) Alleles of the APC gene: An attenuated form of familial polyposis. Cell 75:951–957.
Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. (1993) Mutations of a NutS homolog in hereditary non-polyposis colorectal cancer. Cell 75:1215–1235.
Nicolaides NC, Papadopoulos N, Liu B, Wei Y, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, et al. (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 271:75–80.
Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLHl is associated with hereditary non-polyposis colon cancer. Nature 368:258–261.
Papadopoulos N, Nicolaides NC, Wei YF, et al. (1994) Mutation of a mutL homolog in hereditary nonpolyposis colorectal cancer. Science 263:1625–1629.
Lynch HT, Guirgis HA, Brodkey F, Maloney K, Lynch PM, Rankin L, Lynch JF (1976) Early age of onset in familial breast cancer: Genetic and cancer control implications. Arch Surg 111:126.
Lynch HT, ed. (1981) Genetics and Breast Cancer. New York: Van Nostrand Reinhold Co.
Lynch PM, Lynch HT, eds. (1985) Colon Cancer Genetics. New York: Van Nostrand Reinhold.
Lynch HT, Bewtra C, Lynch JF (1986) Familial ovarian carcinoma: Clinical nuances. Am J Med 81:1073–1076.
Harris RE, Lynch HT, Guirgis HA (1978) Familial breast cancer: Risk to the contralateral breast. J Natl Cancer Inst 60:955–960.
Lynch HT, Krush AJ, Lemon HM, Kaplan AR, Condit PT, Bottomley RH (1972) Tumor variation in families with breast cancer. JAMA 222:1631–1635.
Lynch HT, Lynch PM (1979) Tumor variation in the Cancer Family Syndrome: Ovarian cancer. Am J Surg 138:439.
Lynch HT, Fusaro RM, eds. (1982) Cancer-Associated Genodermatoses. New York: Van Nostrand Reinhold Co.
Guirgis HA, Lynch HT, eds. (1985) Biomarkers, Genetics, and Cancer. New York: Van Nostrand Reinhold.
Lynch HT, Kullander S. (1987) Cancer Genetics in Women. Boca Raton, FL: CRC Press.
Lynch HT, Brodkey FD, Lynch P, Lynch J, Maloney K, Rankin L, Kraft C, Swartz M, Westercamp T, Guirgis HA (1976) Familial risk and cancer control. JAMA 236:582–584.
Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT (1996) Hereditary breast cancer. Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697–709.
Lynch HT, Albano WA, Recabaren J, Lynch PM, Lynch JF, Elston RC (1981) Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. Med Hypothoses 7:1201–1209.
Albano WA, Recabaren JA, Lynch HT, Campbell AS, Mailliard JA, Organ CH, Lynch JF, Kimberling WJ (1982) Natural history of hereditary cancer of the breast and colon. Cancer 50:360–363.
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset breast cancer to chromosome 17q21. Science 250:1684–1689.
Easton DF, Bishop DT, Ford D, Crockford GP, and the Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 52:678–701.
Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BAJ, Weber BL, Garber JE, Birch JM, et al. (1995) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 56:254–264.
Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, et al. (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120–122.
Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 56:265–271.
Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343:692–695.
Steichen-Gersdorf E, Gallion HH, Ford D, Girodet C, Easton DF, DiCioccio RA, Evands G, et al. (1994) Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21. Am J Hum Genet 55:870–875.
Struewing JP, Brody LC, Erdos MR, Kase RG, Glambarresi TR, Smith SA, Collins FS, Tucker MA (1995) Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 57:1–7.
Friedman LS, Szabo CI, Ostermeyer EA, et al. (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57:1284–1297.
Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, et al. (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8:392–398.
Gayther SA, Warren W, Mazoyer S, et al. (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genetics 11:428–433.
Chen Y, Chen C, Riley DF, Allred DC, Chen P, Von Hoff D, Osborne CK, Lee W (1995) Aberrant subcellular localization of BRCA1 in breast cancer. Science 270:789–791.
Schutte M, de Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E, Weinstein CL, Bittner M, Meitzer PS, Trent JM, et al. (1995) Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci USA 92:5950–5954.
Devilee P, Cornelisse CJ (1994) Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198:113–130.
Cleton-Jansen A-M, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ, Stratton MR (1995) Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer 72:1241–1244.
Lynch HT, Fitzsimmons ML, Conway T, Bewtra C, Lynch JF (1990) Hereditary carcinoma of the ovary and associated cancers: A study of two families. Gynecol Oncol 36:48.
Houlston RS, Peto J, Eeles R, Ponder B, Easton D, Horwish A, eds. (1995) Genetic Predisposition to Cancer. London: Chapman and Hall.
Claus EB, Risch N, Thompson WD (1990) Age of onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131:961–972.
Schildkraut JM, Risch N, Thompson WD (1989) Evaluating genetic association among ovarian, breast, and endometrial cancer: Evidence for a breast/ovarian cancer relationship. Am J Hum Genet 45:521–529.
Goldgar DE, Fields P, Tran TD, Cannon-Albright LA, Ward JH, Swensen J, Skolnick MH (1994) A large kindred with 17q-linked breast and ovarian cancer: Genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst 86:200–209.
Peto J, Easton DF, Matthews FE, Ford D, Swerdlow AJ (1996) Cancer mortality in relatives of women with breast cancer: The OPCS study. Int J Cancer 65:275–283.
Ford D, Easton DF (1995) The genetics of breast and ovarian cancer. Br J Cancer 72:805–812.
Ponder BAJ, Easton DF, Peto J (1991) Risk of ovarian cancer associated with a family history: Preliminary report of the OPCS study. In: Sharp F, et al. eds. Ovarian Cancer: Biological and Therapeutic Challenges. New York: W.W. Norton, pp. 3–6.
Amos CI, Shaw GL, Tucker MA, Hartge P (1992) Age at onset for familial epithelial ovarian cancer. JAMA 268:1896–1899.
Prior P, Waterhouse JA (1981) Multiple primary cancers of the breast and ovary. Br J Cancer 44:628–636.
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) A systematic population based assessment of cancer risk in first degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1608.
Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, et al. (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 273:535–541.
Serova O, Montagna M, Torchard D, Narod SA, Tonin P, Sylla B, Lynch HT, Feunteun J, Lenoir GM (1996) A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 58:42–51.
Lynch HT, Watson P, Lynch JF, Conway TA, Fili M (1993) Hereditary ovarian cancer. Heterogeneity in age at onset. Cancer 71:573–581.
Doll R, Peto R (1976) Mortality in relation to smoking: 20 year’s observations on male British doctors. Br Med J 2:1525.
Doll R (1977) Strategy for detection of cancer hazards to man. Nature 265:589.
Fearon EB, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767.
Parazzinni F, Franchesi S, LaVecchia C, Fasoli M (1991) The epidemiology of ovarian cancer. Gynecol Oncol 43:9–23.
Fathalla MF (1971) Incessant ovulation — a factor in ovarian neoplasia?. Lancet 2:163.
Fathalla MF (1972) Factors in the causation and incidence of ovarian cancer. Obstet Gynecol Surv 27:751–768.
Greggi S, Genuardi M, Benedetti-Panici P, et al. (1990) Analysis of 138 consecutive ovarian cancer patients: Incidence and characteristics of familial cases. Gynecol Oncol 39:300–304.
Kerber RA, Slattery ML (1995) The impact of family history on ovarian cancer risk: The Utah population database. Arch Intern Med 155:905–912.
Gwinn JL, Lee NC, Rhodes PH, Layde PM, Rubin GL (1990) Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiop 43:559.
Nandakumar A, Anantha N, Dhar M, Ahuja V, Kumar R, Reddy S, Venugopal T, Rajanna, Vinutha AT, Srinivas (1995) A case-control investigation on cancer of the ovary in Bangalore, India. Int J Cancer 63:361–365.
Bewtra C, Watson P, Conway T, Read-Hippee C, Lynch HT (1992) Hereditary ovarian cancer: A clinicopathological study. Int J Gynecol Pathol 11:180–187.
Piver MS, Baker TR, Jishi MF, et al. (1993) Familial ovarian cancer: A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991. Cancer 71:582–588.
Narod SA, Madlensky L, Bradley L, Cole D, Tonin P, Rosen B, Risch HA (1994) Hereditary and familial ovarian cancer in Southern Ontario. Cancer 74:2341–2346.
Shelling AN, Cooke IE, Ganesan TS (1995) The genetic analysis of ovarian cancer. Br J Cancer 72:521–527.
Taylor RR, Teneriello MG, Nash JD, Park PC, Birrer MJ (1994) The molecular genetics of gyn malignancies. Oncology 8(10):63–73.
Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ (1993) p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 53:3103–3108.
Zheng J, Benedict, Xu H, Hu S, Kim TM, Velicescu M, Wan M, Cofer KF, Dubeau L (1995) Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary dystadenomas. J Natl Cancer Inst 87:1146–1153.
Kappes S, Milde-Langosch K, Kressin P, Passlack B, Dockhorn-Dworniczak B, Rohlke P, Loning T (1995) p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry. Int J Cancer 64:52–59.
Wertheim I, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC (1994) p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst 86:1549–1551.
Liu E, Nuzum C (1995) Molecular sleuthing: Tracking ovarian cancer progression. J Natl Cancer Inst 87:1099–1101.
Abeln ECA, Kuipers-Dijkshoorn NJ, Berns EMJJ, Hensen-Logmans SC, Fleuren GJ, Cornelisse CJ (1995) Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence. Br J Cancer 72:1130–1136.
Park T, Felix JC, Wright TC Jr (1995) X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinoma. Cancer Res 55:4793–4796.
Rigby PW (1995) Gene therapy: A long and winding road. Curr Opin Gen Dev 5:397–398.
Santoso JT, Tang D-C, Lane SB, Hung J, Reed DJ, Muller CY, Carbone DP, Lucci JA III, Miller DS, Mathis JM (1995) Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol Oncol 59:171–178.
Berchuck A, Bast RC Jr. (1995) p53-based gene therapy of ovarian cancer: Magic bullet?. Gynecol One 59:169–170.
Hung M, Matin A, Zhang Y, Xing X, Sorgi F, Huang L, Yu D (1995) Her-2/neu-targeting gene therapy — a review. Gene 159:65–71.
Tobacman JK, Tucker MA, Kase R, et al. (1982) Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer-prone families. Lancet 11:795–797.
Chen KT, Schooley JL, Flam MS (1985) Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome. Obstet Gynecol 66(Suppl):93S–94S.
Lynch HT, Bewtra C, Lynch JF (1986) Familial peritoneal ovarian carcinomatosis. Med Hypotheses 21:171.
Lynch HT, Watson P, Bewtra C, Conway TA, Hippee CR, Kaur P, Lynch JF, Ponder BA (1991) Hereditary ovarian cancer, heterogeneity in age at diagnosis. Cancer 67:1460–1466.
Struewing JP, Watson P, Easton DF, Ponder BAJ, Lynch HT, Tucker MA (1995) Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst Monogr 17:33–35.
NIH Consensus Development Panel on Ovarian Cancer (1995) JAMA 273:491–497.
Schwartz M, Lerman C, Daly M, Audrain J, Masny A, Griffith K (1995) Utilization of ovarian cancer screening by women at increased risk. Cancer Epidemiol Biomarkers Prev 4:269–273.
Lynch HT, Severin MJ, Mooney MJ, Lynch J (1995) Insurance adjudication favoring prophylactic surgery in hereditary breast-ovarian cancer syndrome. Gynecol Oncol 57:23–26.
Katskee v. Blue Cross/Blue Shield of Nebraska, k. 1994, Nebraska Supreme Court No. S-92-1002.
Beggs v. Pacific Mutual Life Insurance Company, 171 Ga. App. 204, 218 S.E. 2d 836. b. 1984.
Cheney v. Bell National Life, 315 Md. 761, 556 A.2d 1135, c. 1989.
Silverstein v. Metropolitan Life Insurance Company, 171 N.E. 914. s. 1930.
Lynch HT, Krush AJ, Larsen AL, Magnuson CW (1966) Endometrial carcinoma: Multiple primary malignancies, constitutional factors, and heredity. Am J Med Sci 252:381.
Nyholm HCH, Nielsen AL, Norup P (1993) Endometrial cancer in postmenopausal women with and without previous estrogen replacement treatment: Comparison of clinical and histopathological characteristics. Gynecol Oncol 49:229–235.
Lynch HT, Lynch J, Conway T, Watson P, Coleman RL (1994) Familial aggregation of carcinoma of the endometrium. Am J Obstet Gynecol 171:24–27.
Lynch HT, Cavalieri RJ, Lynch JF, Casey MJ (1992) Gynecologic cancer clues to Lynch Syndrome II diagnosis: A family report. Gynecol Oncol 44:198–203.
Watson P, Lynch HT (1993) Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677–685.
Sandles LG, Shulman LP, Elias S, Photopulos GJ, Smiley LM, Posten WM, Simpson JL (1992) Endometrial adenocarcinoma: Genetic analysis suggesting heritable site-specific uterine cancer. Gynecol Oncol 47:167–171.
Boland CR (1978) Cancer family syndrome: A case report and literature review. Am J Dig Dis 23:25s–27s.
Lynch HT, Kimberling W, Albano W, Lynch JF, Biscone K, Schuelke GS, Sandberg AA, Lipkin M, Deschner EE, Mikol YB, et al. (1985) Hereditary nonpolyposis colorectal cancer: Parts I and II. Cancer 56:934–951.
Lynch HT, Lanspa SJ, Smyrk TC, et al. (1992) Heterogeneity, natural history and management aspects of Lynch syndrome. In: Rossini FP, et al., eds. Recent Progress in Colorectal Cancer: Biology and Management of High Risk Groups. Amsterdam: Excerpta Medica, pp. 231–235.
Utsunomiya J, Lynch HT (1990) Hereditary Colorectal Cancer. Tokyo: Springer-Verlag.
Lynch HT, Krush AJ (1971) Cancer family ‘G’ revisited: 1895-1970. Cancer 27:1505–1511.
Lynch HT, Ens JA, Lynch JF (1990) The Lynch syndrome II and urological malignancies. J Urol 143:24–28.
Cristofaro G, Lynch HT, Caruso ML, Attolini A, DiMatteo G, Giorgio P, Senatore S, Argentieri A, Sbano E, Guanti G, et al. (1987) New phenotypic aspects in a family with Lynch syndrome II. Cancer 60:51–58.
Lynch HT, Smyrk TC, Lynch PM, Lanspa SJ, Boman BM, Ens J, Lynch JF, Strayhorn P, Carmody T, Cristofaro G (1989) Adenocarcinoma of the small bowel in Lynch syndrome II. Cancer 64:2178–2183.
Lynch HT, Voorhees GJ, Lanspa SJ, McGreevy PS, Lynch JF (1985) Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: A family study. Br J Cancer 52:271–273.
Mecklin J, Jarvinen HJ, Virolainen M (1992) The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma. Cancer 69:1112–1114.
Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF (1985) Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome. Br J Dermatol 113:295–301.
Lynch HT, Kriegler M, Christiansen TA, Smyrk T, Lynch JF, Watson P (1988) Laryngeal carcinoma in a Lynch syndrome II kindred. Cancer 62:1007–1013.
Law IP, Herberman RB, Oldham RK, Bouzoukis J, Hanson SM, Rhode MC (1977) Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies: Clinical description. Cancer 39:1224–1228.
Love RR (1985) Small bowel cancers, B-cell leukemia, and six primary cancers with matastases and prolonged survival in the Cancer Family Syndrome of Lynch. Cancer 55:499–502.
Watson P, Vasen HFA, Mecklin J, Jarvinen H, Lynch HT (1994) The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 96:516–520.
Fink DJ, Mettlin CJ, Murphy GP, Lawrence W Jr., Lenhard RE, eds. (1995) Cancer detection: The cancer-related checkup guidelines. American Cancer Society Textbook of Clinical Oncology, 2nd ed. Atlanta: American Cancer Society, Inc., pp. 178–193.
Enomoto T, Fujita M, Inoue M, Nomura T, Shroyer KR (1995) Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado. Am J Clin Pathol 103:224–230.
Duggan BD, Felix JC, Muderspach LI, Tsao JL, Shibata DK. (1994) Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. Cancer Res 54:1604–1607.
Enomoto T, Fujita M, Inoue M, Rice JM, Nakajima R, Tanizawa O, Nomura T (1993) Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Cancer Res 53:1883–1888.
Ignar-Trowbridge D, Risinger JI, Dent GA, Kohler M, Berchuck A. McLachlan JA, Boyd J (1992) Mutations of the Ki-ras oncogene in endometrial carcinoma. Am J Obstet Gynecol 167:227–232.
Sasano H, Ito K, Garrett CT (1995) Oncogenes and tumor-suppressor genes in gynecological malignancies. In: Garrett CT, Sell S, et al. eds. Cellular Cancer Markers. Totowa, NJ: Humana Press, pp. 111–138.
Kohler MF, Nishii H, Humphrey PA, Sasaki H, Marks JR, Bast RC, Clarke-Pearson DL, Berchuck A (1993) Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias. Am J Obstet Gynecol 169:690–694.
Yu CCW, Wilkinson N, Brito MJ, Buckley CH, Fox H, Levision DA (1993) Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium. Histopathology 23:367–371.
Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J, Shibata D (1994) Microsatellite instability in sporadic endometrial carcinoma. J Natl Cancer Inst 86:1216–1221.
Burks RT, Kessis TD, Cho KR, Hedrick L (1994) Microsatellite instability in endometrial carcinoma. Oncogene 9:1163–1166.
Risinger JI. Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J (1994) Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 53:5100–5103.
Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Nystrom-Lahti M, Seruca R, et al. (1993) Microsatellite instability is associated with tumors that characterize the hereditary nonpolyposis colorectal cercinoma syndrome. Cancer Res 53:5853–5855.
Katabuchi H, van Rees B, Lambers AR, Ronnett BM, Blazes MS, Leach FS, et al. (1995) Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Res 55:5556–5560.
Parsons R, Myeroff L, Liu B, Wilson JKV, Markowitz S, Kinzler KW, Vogelstein B (1995) Microsatellite instability and mutations of the transforming growth factor ß type II receptor gene in colorectal cancer. Cancer Res 55:5548–5550.
Myeroff LL, Parsons R, Kim S, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, et al. (1995) A transforming growth factor ß receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55:5545–5547.
Kurman RJ, Kaminski PF, Norris HJ (1985) The behavior of endometrial hyperplasia. A long term study of ‘untreated’ hyperplasia in 170 patients. Cancer 56:403–412.
Sasaki H, Nishii H, Takahashi, Tada A, Furusato M, Terashima Y, Siegal GP, Partker SL, Kohler MF, Berchuck A, et al. (1993) Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res 53:1906–1910.
Aaltonen LA, Peltomaki P, Mecklin JP, Jarvinen H, Jass JR, Green JS, Lynch HT, Watson P, Tallqvist G, Juhola M, et al. (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54:1645–1648.
Williard W, Borgen P, Bol R, Tiwari R, Osborne M (1992) Cowden’s disease: A case report with analyses at the molecular level. Cancer 69:2969–2974.
Lloyd KMI, Dennis M (1963) Cowden’s disease: A possible new symptom complex with multiple system involvement. Ann Intern Med 58:136–142.
Walton BJ, Morain WB, Baughman RD, et al. (1986) A further indication for prophylactic mastectomy. Surgery 99:82–86.
Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, Ersoy F, Foroud T, Jaspers NGJ, Lange K, et al. (1988) Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 366:577–580.
Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, et al. (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749–1753.
Swift M (1990) Genetic aspects of ataxia-telangiectasia. Immunodefic Rev 2:67–81.
Morrell D, Cromartic E, Swift M (1986) Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 77:89–92.
Morrell D, Chase CL, Swift M (1990) Cancers in 44 families with ataxia-telangiectasia. Cancer Genet Cytogenet 50:119–123.
Swift M, Chase CL, Morrell D (1990) Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet 46:21–27.
Buyse M, Hartman CT, Wilson MG (1976) Gonadoblastoma and dysgerminoma with ataxia-telangiectasia. Birth Defects 12:165–169.
Narita T, Takagi K (1984) Ataxia-telangiectasia with dysgerminomas of the right ovary, papillary carcinoma of the thyroid and adenocarcinoma of the pancreas. Cancer 54:1113–1116.
Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT (1986) The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Human Genet 39:573–583.
Lavin MF, Khanna KK, Beamish H, Teale B, Hobson K, Watters D (1994) Defect in radiation signal transduction in ataxia-telangiectasia. Int J Radiat Biol 66(Supel 6):S151–S156.
Giardiello FM, Welsh SB, Hamilton SR, et al. (1987) Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316:1511.
Utsunomiya J, Gocho H, Miyanaga T (1974) Peutz-Jegher’s syndrome: Its natural course and management. J Hopk Med J 136:71.
Foley TR, McGarrity TJ, Abt AB (1988) Peutz-Jeghers syndrome: A clinicopatholgic survey of the ‘Harrisburg family’ with a 49 year follow-up. Gastroenterology 95:1535–1540.
Ryo UY, Roh SK, Balkin RB, et al. (1978) Extensive metastases in Peutz-Jeghers Syndrome. JAMA 239:2268.
Bowlby LS (1986) Pancreatic adenocarcinoma in an adolescent male with Peutz-Jeghers syndrome. Hum Pathpl 17:97.
Lehur PA, Madarnas P, Devroede G, et al. (1984) Peutz-Jegher’s syndrome — association of duodenal and bilateral breast cancers in the same patient. Dig Dis Sci 29:178.
Lin JI, Caracta PF, Lidner A, Gutzman LG (1977) Peutz-Jegher’s polyposis with metastasizing duodenal carcinoma. South Med J 70:882.
Matuchansky C, Babin P, Coutrot S, Druart F, Barbier J, Maire P. (1979) Peutz-Jegher’s syndrome with metastisizing carcinoma arising from a jejunal hamartoma. Gastroenterology 77:1311.
Utsunomiya J, Maki T, Iwama T, Matsunaga Y, Ichikawa T, Shimomura T, Hamaguchi E, Aoki N (1974) Gastric lesion of familial polyposis coli. Cancer 34:745–754.
Tweedie JH, McCann BG (1984) Peutz-Jeghers syndrome and metastasizing colonic adenocarcinoma. Gut 25:1118.
Elledge RM, Lock-Lim S, Allred DC, Hilsenbeck SG, Cordner L (1995) p53 mutation and tamoxifen restistance in breast cancer. Clin Cancer Res 1:1203–1208.
Wilson DM, Pitts WB, Hintz RL, Rosenfeld RG (1986) Testicular tumors with Peutz-Jeghers Syndrome. Cancer 57:2238.
Abell MR (1966) The nature and classification of ovarian neoplasms. Can Med Assoc J 94:1102–1124.
Scully RE (1979) Tumors of the Ovary and Maldeveloped Gonads. Second Series, Fascicle 16. Washington, DC: Armed Forces Institute of Pathology.
Berg FD, Kurzl R, Hinrichsen MJ, Zander J (1989) Familial 46,XY pure gonadal dysgenesis and gonadoblastomas/dysgerminoma: Case report. Gynecol Oncol 32:261–267.
Kurman RJ, Norris HJ (1977) Malignant germ cell tumors of the ovary. Hum Pathol 8:551–564.
Abell MR, Johnson VJ, Holtz F (1965) Ovarian neoplasms in childhood and adolescence. I. Tumors of germ cell origin. Am J Obstet Gynecol 92:1059–1081.
Norris HJ, Jensen RD (1972) Relative frequency of ovarian neoplasms in children and adolescents. Cancer 30:713–719.
Scully RE (1970) Gonadoblastoma. A review of 74 cases. Cancer 25:1340–1356.
Talerman A (1974) Gonadoblastoma associated with embryonal carcinoma. Obstet Gynecol 43:138–142.
Anderson KC, Li FP, Marchetto DJ (1984) Dizygotic twinning, cryptorchism, and seminoma in a sibling. Cancer 53:374–376.
Arcadia JA (1973) Testicular neoplasms in father and son. J Urol 110:306.
Champlin HW (1930) Similar tumors of testis occurring in identical twins. JAMA 95:96–97.
Shinohara M, Komatsu H, Kawamura T, Yokoyama M (1980) Familial testicular teratoma in 2 children: Familial report and reveiw of the literature. J Urol 123:552–555.
Dieckmann K, Becker T, Jonas D, Bauer HW (1987) Inheritance and testicular cancer. Oncology 44:367–377.
Fuller DB, Plenk HP (1986) Malignant testicular germ cell tumors in a father and two sons. Cancer 58:955–958.
Gawande AS (1980) Histologically similar testicular neoplasms occurring in brothers. J Urol 123:963–964.
Gedde-Dahl T Jr., Hannisdal E, Klepp OH, Grottum KA, Waksvik H, Fossa SD, Stenwig AE, Brogger A (1985) Testicular neoplasms occurring in four brothers. A search for a genetic predisposition. Cancer 55:2005–2009.
Goss PE, Bulbul MA (1990) Familial testicular cancer in five members of a cancer-prone kindred. Cancer 66:2044–2046.
Gulley RM, Kowalski R, Neuhoff CF (1974) Familial occurrence of testicular neoplasms: A case report. J Urol 112:620–622.
Hutter AM, Lynch JJ, Shnider BI (1967) Malignant testicular tumors in brothers. A case report JAMA. 199:1009–1010.
Kubelka J, Sarkar NN, Belitsky P (1983) Familial occurrence of testicular neoplasia: Case report of testicular seminoma in father and son. J Urol 130:140–141.
Lapes M, Iozzi L, Ziegenfus WD, Antoniades K, Vivacqua R (1977) Familial testicular cancer in a father (bilateral seminoma-embryonal cell carcinoma) and son (teratocarcinoma). A case report and review of the literature. Cancer 39:2317–2320.
Levey S, Grabstald H (1975) Synchronous testicular tumors in identical twins. Urology 6:754–758.
Lownes JB, Leberman P (1939) Tumors of the testes in brothers. Urol Cutan Rev 43:205–206.
Mikulicek, Mikulastik J, Sobotka P (1976) Malignant testicular tumors in three brothers. Int Urol Nephrol 8:309–312.
Musa MB (1975) Germ-cell malignant tumours in father and son. Can Med Assoc J 112:1201–1202.
Myers GH Jr., MacPherson BR (1972) Histologically similar testicular neoplasms occurring in brothers. J Urol 108:757–759.
Nicol D, Teh BT, Strachan N, Ward G, Martin N (1994) Familial testicular carcinoma: In search of genetic triggers. Aust N Z J Surg 64:418–420.
Patel SR, Kvols LK, Richardson RL (1990) Familial testicular cancer: Report of six cases and review of the literature. Mayo Clin Proc 65:804–808.
Peschel RE, Schiff M, Knowlton AH (1981) Testicular tumors in 2 families. J Urol 125:432–433.
Raghavan D, Jelihovsky T, Fox RM (1980) Father-son testicular malignancy. Does genetic anticipation occur? Cancer 45:1005–1009.
Raven RW (1934) Tumours of the testis in two brothers. Lancet 2:870–871.
Salm R, Adlington SR (1962) Seminoma in identical twins. Br Med J 2:964–965.
Silber SJ, Cittan S, Friedlander G (1972) Testicular neoplasm in father and son. J Urol 108:889.
Stewart JR, Bagshaw MA (1965) Malignant testicular tumors appearing simultaneously in identical twins. Cancer 18:895–898.
Thomson WO, Sinclair DM (1977) Familial teratoma of testis. Br J Urol 49:322.
Tollerud DJ, Blattner WA, Fraser MC, Brown LM, Pottern L, Shapiro E, Kirkemo A, Shawker TH, Javadpour N, O’Connell K, et al. (1985) Familial testicular cancer and urogenital developmental anomalies. Cancer 55:1849–1854.
Vaccari E (1979) Testicular seminoma in father and son. Case report of testicular malignancies occurring in closely related family members. Andrologia 11:250–254.
Wilbur HJ, Woodruff MW, Welch MS (1979) Concomitant germ cell tumors in monozygotic twins. J Urol 121:538–540.
Wobbes TH, Hoekstra HJ, Oldhoff J, Koops HS (1983) Malignant testicular germ cell tumors in father and son. A report on 2 families. J Urol 129:152–153.
Young JA, Bohne AW (1972) Seminoma in non-twin brothers: A case report. J Urol 107:1000–1001.
Atkin NB, Baker MC (1992) X-chromatin, sex chromosomes, and ploidy in 37 germ cell tumors of the testis. Cancer Genet Cytogenet 59:54–56.
Ilson DH, Bosl GJ, Motzer R, Dmitrovsky E, Chaganti RSK (1991) Genetic analysis of germ cell tumors: Current progress and future prospects. Hematol/Oncol Clin North Am 5:1271–1283.
Parrington JM, West LF, Heyderman E (1994) Chromosome analysis of parallel short-term cultures from four testicular germ-cell tumors. Cancer Genet Cytogenet 75:90–102.
Reilly PA, Heerema NA, Sledge GW Jr., Palmer CG (1993) Unusual distribution of chromosome 12 in a testicular germ-cell tumor cell line (833K) and its cisplatin-resistant derivative (64CP9). Cancer Genet Cytogenet 68:114–121.
Samaniego F, Rodriguez E, Houldsworth J, Murty VV, Ladanyi M, Lele KP, Chen QG, Dmirovsky E, Geller NL, Reuter V, et al. (1990) Cytogenetic and molecular analysis of human male germ cell tumors: Chromosome 12 abnormalities and gene amplification. Genes Chromosom Cancer 1:289–300.
Suijkerbuijk RF, van de Veen AY, van Echten J, Buys CHCM, de Jong B, Oosterhuis JW, Warburton DA, Cassiman JJ, Shonk D, van Kessel AG (1991) Demonstration of the genuine iso-12p character of the standard marker chromosome of testicular germ cell tumors and identification of further chromosome 12 aberrations by competitive in situ hybridization. Am J Hum Genet 48:269–273.
Suijkerbuijk RF, Sinke RJ, Meloni AM, Parrington JM, van Echten J, de Jong B, Oosterhuis JW, Sandberg AA, van Kessel AG (1993) Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ-cell tumors revealed by fluorescence in situ hybridization. Cancer Genet Cytogenet 70:85–93.
Suijkerbuijk RF, Sinke RJ, Olde Weghuis DEM, Roque L, Forus A, Stellink F, Siepman A, van de Kaa C, Soares J, van Kessel AG (1994) Amplification of chromosome subregion 12p11.2-p12.1 in a metastatsis of an I(12p)-negative seminoma: Relationship to tumor progression?. Cancer Genet Cytogenet 78:145–152.
Lynch HT, Krush AJ, Mulcachy GM, Reed WB (1974) Familial occurrences of a variety of premalignant diseases and uncommon malignant neoplasms. Cancer 33:1474–1479.
Mills PK, Newell GR, Johnson DE (1984) Familial patterns of testicular cancer. Urology 14:1–7.
Simpson JL, Photopulos G (1976) The relationship of neoplasia to disorders of abnormal sexual differentiation. Birth Defects 12:15–50.
Ghosh P, Jacobs H, Rattner WH (1976) Testicular neoplasm in siblings. Urology 7:212–213.
Lynch HT, Katz D, Bogard P, Voorheses GJ, Lynch J, Wagner C (1985) Familial embryonal carcinoma in a cancer-prone kindred. Am J Med 78:891–896.
Fetterly JCM (1975) Malignant tumors in father and son. Can Med Assoc J 113:92.
Morrison AS (1976) Cryptochidism, hernia, and cancer of the testis. J Natl Cancer Inst 56:731–733.
Kuber W (1982) Testicular tumor and cryptochidism. Eur J Urol 8:280–283.
Hayakawa M, Mukai K, Nagakura K, Hata M (1986) A case of simultaneous bilateral germ cell tumors arising from cryptorchid testes. J Urol 136:470–472.
Pardo-Mindan FJ, Torcal FV, Julian GG, Ruiz MTV (1975) Familial cryptorchidism. Pediatrics 56:616.
Rezvani I, Rettig KR, DiGeorge AM (1976) Inheritance of cryptorchidism. Pediatrics 58:774–775.
Creizel A, Erodi E, Toth J (1981) Genetics of undescended testis. J Urol 126:528–529.
Aristizabal S, Davis JR, Miller RC, Moore MJ, Boone MLM (1978) Bilateral primary germ cell testicular tumors. Report of four cases and review of the literature. Cancer 42:591–597.
Hamilton JB, Gilbert JB (1942) Studies in malignant tumors of the testis, IV. Bilateral testicular cancer. Incidence, nature, and bearing upon management of the patient with a single testicular cancer. Cancer Res 2:125–129.
Bach DW, Weissbach L, Hartlapp JH (1983) Bilateral testicular tumor. J Urol 129:989–991.
Sokal M, Peckhan MJ, Hendry WF (1980) Bilateral germ cell tumours of the testis. Br J Urol 52:158–162.
Knudson AG, Jr, Strong LC, Anderson DE (1973) Heredity and cancer in man. In: Steinberg AG, Beam AG, eds. Progress in Medical Genetics. New York: Grune & Stratton, pp. 113–158.
Cockburn AG, Vugrin D, Batata M, Hajdu S, Whitmore WF (1983) Second primary germ cell tumors in patients will seminoma of the testis. J Urol 130:357–359.
Simpson JL, Photopulos G (1976) Hereditary aspects of ovarian and testicular neoplasia. Birth Defects 12:51–60.
Atkin NB, Baker MC (1982) Specific chromosome change i(12p) in testicular tumors?. Lancet 2:1349.
Gibas Z, Prout GR, Pontes JE, Sandberg AA (1986) Chromosome changes in germ cell tumors of the testis. Cancer Genet Cytogenet 19:245–252.
Delozier-Blanchet CD, Engel E, Walt H (1985) Isochromosome 12p in malignant testicular tumors. Cancer Genet Cytogenet 15:375–376.
Suijkerbuijk RF, Looijenga L, de Jong B, Oosterhuis JW, Cassiman JJ, van Kessel AG (1992) Verification of isochromosome 12p and identification of other chromosome 12 aberrations in gonadal and extragonadal human germ cell tumors by bicolor double fluorescence in situ hybridization. Cancer Genet Cytogenet 63:8–16.
Rodriguez E, Houldsworth J, Reuter VE, Meitzer P, Zhang J, Trent JM, Bosl GJ, Chaganti RSK (1993) Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromosom Cancer 8:230–236.
Shimogaki H, Kitazawa S, Maeda S, Kamidono S (1993) Variable expression of small hst.l, int-1, and parathyroid hormone-related protein in different histological types of human testicular germ cell tumors. Cancer J 6:81–86.
Jenkyn DJ, McCartney AJ (1987) A chromosome study of three ovarian tumors. Cancer Genet Cytogenet 26:327–337.
Rodriguez E, Melamed J, Reuter V, Chaganti RSK (1995) Chromosome 12 abnormalities in malignant ovarian germ cell tumors. Cancer Genet Cytogenet 82:62–66.
Gibas Z, Talerman A (1993) Analysis of chromosome aneuploidy in ovarian dysgerminoma by flow cytometry and fluorescence in situ hybridization. Diagn Mol Pathol 2:50–56.
Kusyk CJ, Turpening EL, Edwards CL, Warton JT, Copeland LJ (1982) Karyotype analysis of four solid gynecologic tumors. Gynecol Oncol 14:324–338.
Atkin NB, Baker MC (1987) Abnormal chromosomes including small metacentrics in 14 human ovarian cancers. Cancer Genet Cytogenet 26:355–361.
Speleman F, DePotter C, Dal Cin P, Mangelschots K, Ingelaere H, Laureys G, Benoit Y, Leroy J, Van den Berghe H (1990) i(12p) in a malignant ovarian tumor. Cancer Genet Cytogenet 45:49–53.
Hoffner L, Shen-Schwarz S, Deka R, Chakravarti A, Surti U (1992) Genetics and biology of human ovarian teratomas, III. Cytogenetics and origins of malignant ovarian germ cell tumors. Cancer Genet Cytogenet 62:58–65.
Speleman F, Laureys G, Benoit Y, Cuvelier, Suijkerbuijk R, de Jong B (1992) i(12p) in a near diploid nature ovarian teratoma. Cancer Genet Cytogenet 60:216–218.
Vos A, Oosterhuis JW, de Jong B, Castedo SMMJ, Hollema H, Buist J, Aalders JG (1990) Karyotyping and DNA flow cytometry of metastatic ovarian yolk sac tumor. Cancer Genet Cytogenet 44:223–228.
Barakat BY, Ances IG, Tang CK, Fajer AB (1979) 46,XY gonadal dysgenesis with secondary amenorrhea, virilization, and bilateral gonadoblastomas. South Med J 72:1163–1165.
Schellhas HF (1974) Malignant potential of the dysgenetic gonad. Part I. Obstet Gynecol 44:298–309.
Schellhas HF (1974) Malignant potential of the dysgenetic gonad. Part II. Obstet Gynecol 44:455–462.
Szamborski J, Obrebski T, Starzynska J (1981) Germ cell tumors in monozygous twins with gonadal dysgenesis and 46,XY karyotype. Obstet Gynecol 58:120–122.
Troche V, Hernandez E (1986) Neoplasia arising in dysgenetic gonads. Obstet Gynecol 41:74–79.
Talerman A (1971) Gonadoblastoma and dysgerminoma in two siblings with dysgenetic gonads. Obstet Gynecol 38:416–426.
Page DC (1987) Hypothesis: A Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 101(Suppl):151–155.
Lukusa T, Fryns JP, Van den Berghe H (1986) Gonadoblastoma and Y-chromosome fluorescence. Clin Genet 29:311–316.
Amarose AP, Kyriazis AA, Dorus E, Azizi F (1977) Clinical, pathologic, and genetic findings in a cse of 46,XY pure gonadal dysgenesis (Swyer’s syndrome). I. Dysgerminoma and gonadoblastoma. Am J Obstet Gynecol 127:824–828.
Boczkowski K, Teter J, Sternadel Z (1972) Sibship occurrence of XY gonadal dysgenesis with dysgerminoma. Am J Obstet Gynecol 113:952–955.
Isurugi K, Aso Y, Ishida H, Suzuki T, Kakizoe T, Motegi T, Nishi T, Aoki H (1977) Prepubertal XY gonadal dysgenesis. Pediatrics 59:569–573.
Moltz L, Schwartz U, Pickartz H, Hammerstein J, Wolf U (1981) XY gonadal dysgenesis: Aberrant testicular differentiation in the presence of H-Y antigen. Obstet Gynecol 58:17–25.
Petrovic V, Nasioulas S, Chow CW, Voullaire L, Schmidt M, Dahl H (1992) Minute Y chromosome derived marker in a child with gonadoblastoma: Cytogenetic and DNA studies. J Med Genet 29:542–546.
Swyer GIM (1955) Male pseudohermaphroditism: A hitherto undercribed form. Br Med J 2:709–712.
Verp MS, Simpson JL (1987) Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet 25:191–218.
Sarto GE (1974) Cytogenetics of fifty patients with primary amenorrhea. Am J Obstet Gynecol 119:14–23.
Manuel M, Katayama KP, Jones HW Jr. (1976) The age of occurrence of gonadal tumors in interssex patients with a Y chromosome. Am J Obstet Gynecol 124:293–300.
Medlej R, Lobaccaro JM, Berta P, Belon C, Leheup B, Toublanc JE, Weill J, Chevalier C, Dumas R, Sultan C (1992) Screening for Y-derived sex deteriming gene SRY in 40 patients with Turner syndrome. J Clin Endocrinol Metab 75:1289–1292.
Bonadkar ME, Peisner DB (1980) Gonadoblastoma with a 45,XO karyotype. Obstet Gynecol 56:748–750.
Lindsay AN, Sills IN, MacGillivray MH, Fisher JE, Voorhess ML (1981) Brief clinical report: Dysgerminoma in a patient with the syndrome of gonadal dysgenesis with a 45,X karyotype. Am J Med Genet 10:21–24.
Dewhurst J, Ferreira HP (1982) Gonadoblastoma in a patient without gonadal dysgenesis with a Y chromosome. Obstet Gynecol 59:247–249.
Maeyama M, Kagami T, Miyakawa I, Tooya T, Kawasaki N, Iwamasa T (1983) Case report of dysgerminoma in a patient with a 46,XX pure gonadal dysgenesis. Gynecol Oncol 16:405–413.
Govan ADT, Wood AS, Gowing NFC, Langley FA, Neville AM, Anderson MC (1977) A clinico-pathological study of gonadoblastoma. Br J Obstet Gynaecol 84:222–228.
Barbosa AS, Ferraz-Costa TE, Semer M, Liberman B, Moreira-Filho CA (1995) XY gonadal dysgenesis and gonadoblastoma: A study in two sisters wth a cryptic deletion of the Y chromosome involving the SRY gene. Hum Genet 95:63–66.
Tsuchiya K, Reijo R, Page DC, Disteche CM (1995) Gonadoblastoma: Molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 57:1400–1407.
Ostrer H, Henderson AL, Stringer LC (1987) Characterization of Y chromosomal deoxyribonucleic acid fragments and translocations by Southern blot analysis. J Pediatr 111:678–683.
Tho SPT, McDonough PG (1987) Use of Y DNA probes to identify children at risk for dysgenetic gonadal tumors. Clin Obstet Gynecol 30:671–681.
Cooper C, Crolla JA, Laister C, Johnston DI, Cooke P (1991) An investigation of ring and dicentric chromosomes found in three Turner’s syndrome patients using DNA analysis and in situ hybridization with X and Y chromosome specific probes. J Med Genet 28:6–9.
van der Bijl AE, Fleuren GJ, Kenter GG, de Jong D (1994) Unique combination of an ovarian gonadoblastoma, dysgerminoma, and mucinous cystadenoma in a patient with Turner’s syndrome: A cytogenetic and molecular analysis. Int J Gynecol Pathol 13:267–272.
Cohen MM, Shaw MW (1965) Two XY siblings with gonadal dysgenesis and a female phenotype. N Engl J Med 272:1083–1088.
Bruneteau DW, Sipahioglu I, Byrd JR, Greenblatt RB (1976) Pure gonadal dysgenesis with an XY chromosomal constitution (Swyer’s syndrome): Report of two cases. Am J Obstet Gynecol 124:55–59.
Anderson CTJ, Carlson IH (1975) Elevated plasma testosterone and gonadal tumors in two 45XY’ sisters’. Arch pathol 99:360–363.
Ionescu B, Maximilian C (1977) Three sisters with gonadoblastoma. J Med Genet 14:194–199.
Phansey SA, Satterfield R, Jorgenson RJ, Salinas CF, Yoder FE, Mathur RS, Williamson HO (1980) XY gonadal dysgenesis in three siblings. Am J Obstet Gynecol 138:133–138.
Frasier SD, Bashore RA, Mosier HD (1964) Gonadoblastoma associated with pure gonadal dysgenesis in monozygous twins. J Pediatr 64:740–745.
Trentini GP, Palmieri B (1974) An unusual case of gonadic germinal tumor in a brother and sister. Cancer 33:250–255.
Yule SM, Dawes PJ, Malcolm AJ, Pearson AD (1994) Occurrence of seminoma and dysgerminoma in father and daughter. Pediatr Hematol Oncol 11:211–213.
van der Werfften Bosch J (1959) Brachymetacarpal dwarfism (‘pseudo-pseudohypoparathyroidism’) with and without gonadal dysgenesis. Lancet 1:69–71.
Bricarelli FD, Fraccaro M, Lindsten J, Müller U, Baggio P, Lamba Carbone LD, Hjerpe A, Lindgren F, Mayerová A, Ringertz H, et al. (1981) Sex-reversed XY females with campomelic dysplasia are H-Y negative. Hum Genet 57:15–22.
Puck SM, Haseltine FP, Francke U (1981) Absence of H-Y antigen in an XY female with campomelic dysplasis. Hum Genet 57:23–27.
Greenberg F, Gresik MV, Carpenter RJ, Law Sw, Hoffman LP, Ledbetter DH (1987) The Gardner-Silengo-Wachtel or Genito-Palato-Cardiac syndrome: Male pseudohermaphroditism with micrognathia, cleft palate, and conotruncal cardiac defect. Am J Med Genet 26:59–64.
Brosnan PG, Lewandowski RC, Toguri AG, Payer AF, Meyer WJ (1980) A new familial syndrome of 46,XY gonadal dysgenesis with anomalies of ectodermal and mesodermal structures. J Pediatr 97:586–590.
Greenberg F, Keenan B, De Yanis V, Finegold M (1986) Gonadal dysgenesis and gonadoblastoma in situ in a female with Fraser (cryptophthalmos) syndrome. J Pediatr 108:952–954.
Bartlett DJ, Grant JK, Pugh MA, Aherne W (1968) A familial feminizing syndrome. A family showing intersex characteristics with XY chromosomes in three members. J Obstet Gynaecol Brit Cwlth 75:199–210.
Sternberg WH, Barclay DL, Kloeper HW (1968) Familial XY gonadal dysgenesis. N Engl J Med 278:695–700.
Simpson JL, Blagowidow N, Martin AO (1981) XY gonadal dysgenesis: Genetic heterogeneity based upon clinical observations, H-Y antigen status and segregation analysis. Hum Genet 58:91–97.
Mann JR, Cokery JJ, Fisher HJW, Cameron AH, Mayerova A, Wolf U, Kennaugh AA, Woolley V (1983) The X linked recessive form of XY gonadal dysgenesis with a high incidence of gonadal germ cell tumors: Clinical and genetic studies. J Med Genet 20:264–270.
Goldsmith CI, Hart WR (1975) Ataxia-telangiectasia with ovarian gonadoblastoma and contralateral dysgerminoma. Cancer 36:1838–1842.
Buyse M, Hartman CT, Wilson MG (1976) Gonadoblastoma and dysgerminoma with ataxia-telangictasia. Birth Defects 12:165–169.
Weinblatt M, Kochen J (1991) An unusual family cancer syndrome manifested in young siblings. Cancer 68:1068–1070.
Mandel M, Toren A, Kende G, Neuman Y, Kenet G, Rechavi G (1994) Familial clustering of malignant germ cell tumors and Langerhans’ histiocytosis. Cancer 73:1980–1983.
Jackson SM (1967) Ovarian dysgerminoma in three generations?. J Med Genet 4:112–113.
Blake KI, Gerrard MP (1993) Malignant germ cell tumours in two siblings. Med Pediatr Oncol 21:299–300.
Shulman LP, Muram D, Marina N, Jones C, Portera JC, Wachtel SS, Simpson JL, Elias S (1994) Lack of heritablility in ovarian germ cell malignancies. Am J Obstet Gynecol 170:1803–1808.
Seifer DB, Meyers-Seifer CH, Lavy G, Genel M, DeCherney AH, Yang-Feng TL (1991) Laparoscopic adnexectomy in a Turner mosaic female with isodicentric Y. Hum Reprod 6:566–567.
Casey MJ, Bewtra C, Garcia-Padial J. Lynch HT (1995) Laparoscopic examination and assisted bilateral salpingo-oophorectomy, hysterectomy for prophylactic removal of the ovaries and uterus in women at genetic risk for ovarian cancer. J Gynecol Tech 1:111–114.
Cutler BS, Forbes AP, Ingersoll FM, Scully RE (1972) Endometrial carcinoma after stilbestrol therapy in gonadal dysgenesis. N Engl J Med 287:628–631.
McCarty KSJ, Barton TK, Peete CHJ, Creasman WT (1978) Gonadal dysgenesis with adenocarcinoma of the endometium. An electron microscopic and steroid receptor analysis with a review of the literature. Cancer 42:512–520.
Louka MH, Ross RD, Lee JHJ, Lewis GCJ (1978) Endometrial carcinoma in Turner’s syndrome. Gynecol Oncol 6:294–304.
Williams SD, Gershenson DM, Horowitz CJ, et al. (1992) Ovarian germ cell and stromal tumors. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology. Philadelphia: J.B. Lippincott, pp. 715–730.
Kurman RJ, Norris HJ (1976) Endodermal sinus tumor of the ovary: A clinical and pathologic analysis of 71 cases. Cancer 38:2404–2419.
Niloff JM (1992) Tumor markers. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology. Philadelphia: J.B. Lippincott, pp. 137–150.
Feld D, Labes J, Nathason M (1966) Bilateral ovarian dermoid cysts in triplets. Obstet Gynecol 27:525–528.
Plattner G, Oxorn H (1973) Familial incidence of ovarian dermoid cysts. Can Med Assoc J 108:892–893.
Simon A, Ohel G, Neri A, Schenker JG (1985) Familial occurrence of mature ovarian teratomas. Obstet Gynecol 66:278–279.
Corfman PA, Richart RM (1964) Chromosome number and morphology of benign ovarian cystic teratomas. N Engl J Med 271:1241–1244.
Surti U, Hoffner L, Chakravarti A, Ferrell RE (1990) Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin. Am J Hum Genet 47:635–643.
Patil SR, Kaiser-McCaw B, Hecht F, Lindner D, Lovrien EW (1978) Human benign ovarian teratomas: Chromosomal and electophoretic enzyme studies. Birth Defects 14:297–301.
Ohama K, Nomura K, Okamoto E, Fukuda Y, Ihara T, Fujiwara A (1985) Origin of immature teratoma of the ovary. Am J Obstet Gynecol 152:896–900.
Linder D, McCaw BK, Hecht F (1975) Parthenogenic origin of benign ovarian teratomas. N Engl J Med 292:63–66.
Parrington JM, West LF, Povey S (1984) The origin of ovarian teratomas. J Med Genet 21:4–12.
Carritt B, Parrington J, Welch H, Povey S (1982) Diverse origins of multiple ovarian teratomas in a single individual. Proc Natl Acad Sci USA 79:7400–7404.
Bennington JF, Ferguson BR, Haber SL (1968) Incidence and relative frequency of benign and malignant ovarian neoplasms. Obstet Gynecol 32:627–632.
Gee DC, Russell P (1981) The pathological assessment of ovarian neoplasms. IV: The sex cord-stromal tumours. Pathology 13:235–255.
Stenwig JT, Hazekamp JT, Beecham JB (1979) Granulosia cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 7:136–152.
Björkholm E, Silfverswärd C (1981) Prognostic factors in granulosa-cell tumors. Gynecol Oncol 11:261–274.
Young RH, Scully RE (1985) Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 9:543–569.
Scully RE (1970) Sex cord tumor with annular tubules: A distinctive ovarian tumor of the Peutz-Jeghers Syndrome. Cancer 25:1107–1121.
Kuzma JF, King JM (1948) Dyschondroplasia with hemangiomatosis (Maffucci’s syndrome) and teratoid tumor of the ovary. Arch Pathol 46:74–82.
Young RH, Dickersin GR, Scully RE (1984) Juvenile granulosa cell tumor of the ovary: A clinicopathological analysis of 125 cases. Am J Surg Pathol 8:575–596.
Lewis RJ, Ketcham AS (1973) Maffucci’s syndrome: Functional and neoplastic significance. J Bone Joint Surg 55:1465–1479.
Tamimi HK, Bolen JW (1984) Enchondromatosis (Ollier’s disease) and ovarian juvenile granulosa cell tumor: A case report and review of the literature. Cancer 53:1605–1608.
Vaz RM, Turner C (1986) Ollier disease (enchondromatosis) associated with ovarian juvenile granulosa cell tumor and precocious pseudopuberty. J Pediatr 108:945–947.
Jensen RD, Norris HJ, Fraumeni JFJ (1974) Familial arrhenoblastoma and thyroid adenoma. Cancer 33:218–223.
O’Brien PK, Wilansky DL (1981) Familial thyroid nodulation and arrhenoblastoma. Am J Clin Pathol 75:578–581.
Whitcomb RW, Calkins JW, Lukert BP, Kyner JL, Schimke RN (1986) Androblastomas and thyroid disease in postmenopausal sisters. Obstet Gynecol 67:89S–891S.
Murad TM, Mancini R, George J (1973) Ultrastructure of a virilizing ovarian Sertoli-Leydig cell: Tumor with familial incidence. Cancer 31:1440–1450.
Young RH, Scully RE (1984) Ovarian Sertoli cell tumors: A report of ten cases. Int J Gynecol Pathol 2:349–363.
Sohl HM, Azoury RS, Najjar SS (1983) Peutz-Jeghers syndrome associated with precocious puberty. J Pediatr 103:593–595.
Dozois RR, Kempers RD, Dahlin DC, Bartholomew LG (1970) Ovarian tumors associated with the Peutz-Jeghers syndrome. Ann Surg 172:233–238.
Burdick D, Prior JT, Scanion GT (1963) Peutz-Jeghers syndrome: A clinical-pathological study of a large family with a 10-year follow-up. Cancer 16:854–867.
Dickson WB (1944) Multiple adenomas of the jejunum. Ann Surg 119:283–286.
Reid JD (1965) Duodenal carcinoma in the Peutz-Jeghers syndrome. Report of a case. Cancer 18:970–977.
Tseng HL, Braunstein L (1954) Polyposis of small intestine. Gastroenterology 27:426–430.
Young RH, Welch WR, Dickersin GR, Scully RE (1982) Ovarian sex cord tumor with annular tubules. Review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 50:1384–1402.
Srivatsa PJ, Keeney GL, Podratz KC (1994) Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers Syndrome. Gynecol Oncol 53:256–264.
Clendenning WE, Herdt JR, Block JB (1963) Ovarian fibromas and mesenteric cysts: Their association with hereditary basal cell cancer of the skin. Am J Obstet Gynecol 87:1008–1012.
Gorlin RJ, Vickers RA, Kelln E, Williamson JJ (1965) The multiple basal-cell nevi syndrome. An analysis of a syndrome consisting of multiple nevoid basal-cell carcinoma, jaw cysts, skeletal anomalies, medulloblastoma, and hyporesponsiveness to parathormone. Cancer 18:89–104.
Berlin NI, Van Scott EJ, Clendenning WE, Archard HO, Block JB, Witkop CJ, Haynes HA (1966) Basal cell nevus syndrome. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med 64:403–421.
Gorlin RJ, Sedano HO (1971) The multiple nevoid basal cell carcinoma syndrome revisited. Birth Defects 7:140–148.
Burket RL, Rauh JL (1976) Gorlin’s syndrome: Ovarian fibromas at adolescence. Obstet Gynecol 47:43S–46S.
Raggio M, Kaplan AL, Harberg JF (1983) Recurrent ovarian fibromas with basal cell nevus syndrome (Gorlin syndrome). Obstet Gynecol 61:95S–96S.
Gorlin RJ (1987) Nevoid basal-cell carcinoma syndrome. Medicine 66:98–113.
Dockerty MB, Masson JC (1944) Ovarian fibromas: A clinical and pathologic study of two hundred and eighty-three cases. Am J Obstet Gynecol 47:741–752.
Kraemer BB, Silva EG, Sneige N (1984) Fibrosarcoma of ovary. A new component in the nevoid basal-cell carcinoma syndrome. Am J Surg Pathol 8:231–236.
Miller ME, Chatten J (1967) Ovarian changes in ataxia telangiectasia. Acta Paediatr Scand 56:559–561.
Gotoff SP, Amirmokri E, Liebner EJ (1967) Ataxia telangiectasia: Neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Am J Dis Child 114:617–625.
Taylor AMR, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Steens S, Bridges BA (1975) Ataxia telangiectasia: A human mutation with abnormal radiation sensitivity. Nature 258:427–429.
Cole J, Arlett CF, Green MHL, Harcourt SA, Priestley A, Henderson L, Cole H, James SE, Richmond F (1988) Comparative human cellular radiosensitivity: II. The survival following gamma-irradiation of unstimulated (G0) T-lymphocytes, T-lymphocyte lines, lumphoblastoid cell lines and fibroblasts from normal donors, from ataxia-telangiectasia patients and from ataxia-telangiectasia heterozygotes. Int J Radiat Biol 54:929–943.
Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831–1836.
Swift M, Reitnauer PJ, Morrell D, Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289–1294.
Cunliffe PN, Mann JR, Cameron AH, Ward HWC (1975) Radiosensitivity in ataxia-telangiectasia. Br J Radiol 48:374–376.
Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT (1986) The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet 39:573–583.
Dumont-Herskowtiz RA, Safaii HS, Senior B (1978) Ovarian fibromata in four successive generations. J Pediatr 93:621–624.
Fletcher JA, Gibas Z, Donovan K, Perez-Atayde A, Genest D, Morton CC, Lage JM (1991) Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. Am J Pathol 138:515–520.
Schofield DE, Fltecher JA (1992) Trisomy 12 in pediatric granulosa-stromal cell tumors. Demonstration by a modified method of fluroescence in situ hybridization on paraffinembedded material. Am J Pathol 141:1265–1269.
Taruscio D, Carcangiu ML, Ward DC (1993) Detection of trisomy 12 on ovarian sex cord stromal tumors by fluorescence in situ hybridization. Diagn Mol Pathol 2:94–98.
Leung W, Schwartz PE, Ng H, Yang-Feng TL (1990) Trisomy 12 in benign fibroma and granulosa cell tumor of the ovary. Gynecol Oncol 38:28–31.
Mrozek KB, Babinska M, Mrozek E, Hrabowska M, Emerich J, Limon J (1990) Trisomy of chromosome 12 in a case of thecoma of the ovary. Gynecol Oncol 36:413–416.
Pejovic T, Heim S, Mandahl N, Elmfors B, Floderus UM, Furgyik S, Helm G, Willen H, Mitelman F (1990) Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors. Genes Chromosom Cancer 2:48–52.
Cal Cin P, Moerman P, DeWever I, Van den Berghe H (1992) Numerical chromoome aberrations in fibrothecoma. Tumori 78:140–142.
Rodriguez E, Rao PH, Reuter V (1992) Cytogenetic analysis of a juvenile granulosa cell tumor. Cancer Genet Cytogenet 61:207–209.
Tharapel SA, Qumsiyeh MB, Photopulos G (1991) Numerical chromosome abnormalities associated with early clinical stages of gynecologic tumors. Cancer Genet Cytogenet 55:89–96.
Teyssier J, Adnet J, Pideon F, Bajolle F (1985) Chromosomal changes in an ovarian granulosa cell tumor: Similarity with carcinoma. Cancer Genet Cytogenet 14:147–152.
Persons DL, Hartmann LC, Herath JF, Keeney GL, Jenkins RB (1994) Fluroescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol 102:775–779.
Shashi V, Gollden WL, von Kap-Herr C, Andersen WA, Gaffey MJ (1994) Interphase fluroescence in situ hybribization for trisomy 12 on archival ovarian sex cord-stromal tumors. Gynecol Oncol 55:349–354.
Wolf NG, Lage JM (1995) Genetic analysis of gestational trophoblastic disease: A review. Semin Oncol 22:113–120.
Lindor NM, Ney JA, Gaffey TA, Jenkins RB, Thibodeau SN, Dewald GW (1992) A genetic review of complete and partial hydatidiform moles and nonmolar triploidy. Mayo Clin Proc 67:791–799.
Roberts DJ, Mutter GL (1994) Advances in the molecular biology of gestational trophoblastic disease. J Reprod Med 39:201–208.
Fujita N, Tamura S, Shimizu N, Nozawa S (1994) Genetic origin analysis of hydatidiform mole and non-molar abortion using the polymerase chain reaction method. Acta Obstet Gynecol Scand 73:719–725.
LaVecchia C, Franceschi S, Fasoli M, Mangioni C (1982) Gestational trophoblastic neoplasms in homozygous twins. Obstet Gynecol 60:250–252.
Ambani LM, Vaidya RA, Rao CS, Daftary SD, Motashaw ND (1980) Familial occurrence of trophoblastic disease — report of recurrent molar pregnancies in sisters in three families. Clin Genet 18:27–29.
Seoud M, Khalil A, Frangieh A, Zahed L, Azar G, Nuwayri-Salti N (1995) Recurrent molar pregnancies in a family with extensive intermarriage: Report of a family and review of the literature. Obstet Gynecol 86:692–695.
Parazzini F, LaVecchia C, Franceschi S, Mangili G (1984) Familial trophoblastic disease: Case report. Am J Obstet Gynecol 149:382–383.
Iliya FA, Williamson S, Azar HA (1967) Choriocarcinoma in the Near East. Consanguinity as a possible etiologic factor. Cancer 20:144–149.
Novak E, Novak ER (1956) Hydatidiform mole. In: Textbook of Gynecology, 5th ed. Baltimore, MD: Williams and Wilkins, pp. 767–787.
Teoh ES, Dawood MY, Ratnam SS (1972) Observations on choriocarcinoma in Singapore. Obstet Gynecol 40:519–524.
Jones WB, Lewis JL Jr. (1974) Treatment of gestational trophoblastic disease. Am J Obstet Gynecol 120:14–20.
Yamashita K, Wake N, Araki T, Ichinoe K, Makoto K (1979) Human lymphocyte antigen expression in hydatidiform mole: Androgenesis following fertilization by a haploid sperm. Am J Obstet Gynecol 135:597–600.
Robinson E, Shulman J, Ben-Hur N, Zuckerman H, Neuman Z (1963) Immunological studies and behavior of husband and foreign homografts in patients with chorionepithelioma. Lancet 1:300–302.
Mathe G, Dausset J, Hervet E, Amiel JL, Colombani J, Brule G (1964) Immunological studies in patients with placental choriocarcinoma. J Natl Cancer Inst 33:193–208.
Robinson E, Ben-Hur N, Zuckerman H, Neuman Z (1967) Further immunologic studies in patients with choriocarcinoma and hydatidiform mole. Cancer Res 27:1202–1204.
Gilboa-Garber N, Nelken D (1961) Specific antigens of human leucocytes and thrombocytes. Nature 192:466–467.
Robinson E, Nelken D (1965) Individual specific leukocyte antigens in patients with malignant neoplasia. Cancer Res 25:725–726.
Barnstable CJ, Jones EA (1978) Isolation, structure and genetics of HLA-A,-B,-C and-DRw (Ia) antigens. Br Med Bull 34:241–246.
Travers PJ, Arklie JL, Trowsdale J, Patillo RA, Bodmer WF (1982) Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines. Natl Cancer Inst Monogr 60:175–180.
Berkowitz RS, Umpierre SA, Taylor-Emery S, Goldstein DP, Anderson DJ (1986) Immunobiology of complete molar pregnancy and gestational trophoblastic tumor. Cancer Metast Rev 5:109–123.
Lawler SD (1978) HLA and trophoblastic tumours. Br Med Bull 34:305–308.
Bagshawe KD, Lawler SD (1982) Choriocarcinoma. In: Schottenfeld D, Fraumeni JF Jr., eds. Cancer Epidemiology and Prevention. Philadelphia: W.B. Saunders, pp. 909–924.
Bagshaw KD (1976) Risk and prognostic factors in trophoblastic neoplasia. Cancer 38:1373–1385.
Yamashita K, Ishikawa M, Shimizu T, Kuroda M (1981) HLA antigens in husband-wife pairs with trophoblastic tumor. Gynecol Oncol 12:68–74.
Berkowitz RS, Hornig-Rohan J, Martin-Alosco S, Klein S, Goldstein DP, Bast RC, DeWolf WC (1981) H-LA antigen frequency distribution in patients with gestational choriocarcinoma and their husbands. Placenta 3:263–267.
Mittal KK, Kachru RB, Brewer JI (1975) The HL-A and ABO antigens in trophoblastic disease. Tissue Antigens 6:57–69.
Lewis JL Jr., Terasaki PI (1971) HL-A leukocyte antigen studies in women with gestational trophoblastic neoplasms. Am J Obstet Gynecol 111:547–554.
Kanazawa K, Kajino T, Takeuchi S (1986) Studies on antilymphocyte antibodies in gestational choriocarcinoma. Hum Reprod 1:519–522.
Jones EA, Bodmer WF (1980) Lack of expression of HLA antigens on choriocarcinoma cell lines. Tissue Antigens 16:195–202.
Trowsdale J, Travers P, Bodmer WF, Patillo RA (1980) Expression of HLA-A,-B, and-C and ß2-microglobulin antigens in human choriocarcinoma cell lines. J Exp Med 152:11s–17s.
Berkowitz RS, Hoch EJ, Goldstein DP, Anderson DJ (1984) Histocompatibility antigens (HLA-A,B,C) are not detectable in molar villous fluid. Gynecol Oncol 19:74–78.
Berkowitz RS, Anderson DJ, Hunter NJ, Goldstein DP (1983) Distribution of major histocompatibility (HLA) antigens in chorionic villi of molar pregnancy. Am J Obstet Gynecol 146:221–222.
Yamashita K, Nakamura T, Shimizu T (1984) Absence of major histocompatibility complex antigens in choriocarcinoma. Am J Obstet Gynecol 150:896–897.
Lawler SD, Klouda PT, Bagshawe KD (1976) The relationship between HLA antibodies and the causal pregnancy in choriocarcinoma. Br J Obstet Gynaecol 83:651–655.
Tomoda Y, Fuma M, Saiki N, Ishizuka N, Akaza T (1976) Immunologic studies in patients with trophoblastic neoplasia. Am J Obstet Gynecol 126:661–667.
Messerli ML, Lilienfeld AM, Parmley T, Woodruff JD, Rosenshein NB (1985) Risk factors for gestational trophoblastic neoplasia. Am J Obstet Gynecol 153:294–300.
Szulman AE, Surti U (1982) The clinicopathologic profile of partial hydatidorm mole. Obstet Gynecol 59:597–602.
Arima T, Imamura T, Amada S, Tsuneyoshi M, Wake N (1994) Genetic origin of malignant trophoblastic neoplasms. Cancer Genet Cytogenet 73:95–102.
Azuma C, Saji F, Tokugawa Y, Kimura T, Nobunaga T, Takemura M, Kameda T, Tanizawa O (1991) Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: The detection of anuclear empty ovum as the cause of complete mole. Gynecol Oncol 40:29–33.
Chaganti RSK, Koduru PRK, Chakraborty R, Jones WB (1990) Genetic origin of a trophoblastic choriocarcinoma. Cancer Res 50:6330–6333.
Davis JR, Kerrigan DP, Way DL, Weiner SA (1987) Partial hydatidiform moles: Deoxyribonucleic acid content and course. Am J Obstet Gynecol 157:969–973.
Doshi N, Surti U, Szulman AE (1983) Morphologic anomalies in triploid liveborn fetuses. Hum Pathol 14:716–723.
Fisher RA, Paradinas FJ, Newlands ES, Boxer GM (1992) Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus. Br J Cancer 65:355–358.
Habibian R, Surti U (1987) Cytogenetics of trophoblasts from complete hydatidiform moles. Cancer Genet Cytogenet 29:271–287.
Jacobs PA, Hunt PA, Matsuura JS, Wilson CC, Szulman AE (1982) Complete and partial hydatidiform mole in Hawaii: Cytogenetics, morphology and epidemiology. Br J Obstet Gynecol 89:258–266.
Kajii T, Ohama K (1977) Androgenetic origin of hydatidiform mole. Nature 268:633–634.
Kovacs BW, Shahbahrami B, Tast DE, Curtin JP (1991) Molecular genetic analysis of complete hydatidiform moles. Cancer Genet Cytogenet 54:143–152.
Lage JM, Berkowitz RS, Rice LW, Goldstein DP, Bernstein MR, Weinberg DS (1991) Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor. Obstet Gynecol 77:111–115.
Lage JM, Mark SD, Roberts DJ, Goldstein DP, Bernstein MR, Berkowitz RS (1992) A flow cytometric study of 137 fresh hydropic placentas: Correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol 79:403–410.
Lawler SD, Fisher RA, Pickthall VJ, Povey S, Evans MW (1982) Genetic studies on hydatidiform moles. I. The origin of partial moles. Cancer Genet Cytogenet 5:309–320.
Lawler SD, Povey S, Fisher RA, Pickthall VJ (1982) Genetic studies on hydatidiform moles. II. The origin of complete moles. Ann Hum Genet 46:209–222.
Lawler SD, Fisher RA, Dent J (1991) A prospective genetic study of complete and partial hydatidiform moles. Am J Obstet Gynecol 164:1270–1277.
Pattillo RA, Sasaki S, Katayama KP, Roesler M, Mattingly RF (1981) Adenocarcinoma of the uterine cervix. Obstet Gynecol 73:1005–1008.
Surti U, Szulman AE, Wagner K, Leppert M, O’Brien SJ (1986) Tetraploid partial hydatidiform moles: Two cases with a triple paternal contribution and a 92,XXXY karyotype. Hum Genet 72:15–21.
Szulman AE, Surti U (1978) The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 131:665–671.
Vejerslev LO, Dissing J, Hansen HE, Poulsen H (1987) Hydatidiform mole: Genetic origin in polyploid conceptuses. Hum Genet 76:11–19.
Vejerslev LO, Dissing J, Hansen HE, Poulsen H (1987) Hydatidiform mole: Genetic markers in diploid abortuses with macroscopic villous enlargement. Cancer Genet Cytogenet 26:143–155.
Carr DH (1969) Cytogenetics and the pathology of hydatidiform degeneration. Obstet Gynecol 33:333–342.
Surti U, Szulman AE, O’Brien S (1979) Complete (classic) hydatidiform mole with 46,XY karyotype of paternal origin. Hum Genet 51:153–155.
Berkowitz RS, Goldstein DP, Bernstein MR (1983) Natural history of partial molar pregnancy. Obstet Gynecol 66:677–681.
Berkowitz RS, Goldstein DP (1995) Gestational trophoblastic disease. Cancer 76:2079–2085.
Lathrop JC, Lauchlan S, Nayak R, Ambler M (1988) Clinical characteristics of placental site trophoblastic tumor (PSTT). Gynecol Oncol 31:32–42.
Wake N, Takagi N, Sasaki M (1978) Androgenesis as a cause of hydatidiform mole. J Natl Cancer Inst 60:51–53.
Wallace DC, Surti U, Adams CW, Szulman AE (1982) Complete moles have paternal chromosomes but maternal mitochondrial DNA. Hum Genet 61:145–147.
Wake N, Fujino T, Hoshi S, Shinkai N, Sakai K, Kato H, Hashimoto M, Yasuda T, Ichinoe K (1987) The propensity to malignancy of dispermic heterozygous moles. Placenta 8:319–326.
Kajii T, Kurashige H, Ohama K, Uchino F (1984) XY and XX complete moles: Clinical and morphologic correlations. Am J Obstet Gynecol 150:57–64.
Wake N, Seki T, Fujita H, Okubo H, Sakai K, Okuyama K, Hayashi H, Shiina Y, Sato H, Kuroda M, et al. (1984) Malignant potential of homozygous and heterozygous complete moles. Cancer Res 44:1226–1230.
Kotylo PK, Michael H, Davis TE, Sutton GP, Mark PR, Roth LM (1992) Flow cytometric DNA analysis of placental-site trophoblastic tumors. Int J Gynecol Pathol 11:245–252.
Fukunaga M, Ushigome S (1993) Malignant trophoblastic tumors: Immunohistochemical and flow cytometric compaison of choriocarcinoma and placental site trophoblastic tumors. Hum Pathol 24:1098–1106.
Berkowitz RS, Cramer DW, Bernstein MR, Cassells S, Driscoll SG, Goldstein DP (1985) Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol 152:1016–1020.
Bagshawe KD, Lawler SD, Paradinas FJ, Dent J, Brown P, Boxer GM (1990) Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet 335:1074–1076.
Rice LW, Berkowitz RS, Lage JM, Goldstein DP, Bernstein MR (1990) Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol 36:358–362.
Lurain JR, Brewer JI, Torok EE, Halpern B (1983) Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 145:591–595.
Brewer JI (1958) Hydatidiform mole and choiocarcinoma. In: Textbook of Gynecology, 2nd ed. Baltimore, MD: Williams & Wilkins, pp. 573–584.
Buckley JD (1984) The epidemiology of molar pregnancy and choriocarcinoma. Clin Obstet Gynecol 27:153–159.
Honore LH (1987) Recurrent partial hydatidiform mole: Report of a case. Am J Obstet Gynecol 156:922–924.
Mutter GL, Pomponio RJ, Berkowitz RS, Genest DR (1993) Sex chromosome composition of complete hydatidiform moles: Relationship to metastatsis. Am J Obstet Gynecol 168:1547–1551.
Sheppard DM, Fisher RA, Lawler SD (1985) Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines. Cancer Genet Cytogenet 16:251–258.
Wake N, Tanaka K, Chapman V, Matsui S, Sandberg AA (1981) Chromosomes and cellular origin of choriocarcinoma. Cancer Res 41:3137–3143.
Hemming JD, Quirke P, Womack C, Wells M, Elston CW, Pennington GW (1988) Flow cytometry in persistent trophoblastic disease. Placenta 9:615–621.
Rachmilewitz J, Goshen R, Ariel I, Schneider T, de Groot N, Hochberg A (1992) Parental imprinting of the human H19 gene. FEBS Lett 309:25–28.
Clarke A (1990) Genetic imprinting in clinical genetics. Dev. (Suppl):131–139.
Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP (1993) Relaxation of imprinted genes in human cancer. Nature 362:747–749.
Walsh C, Miller SJ, Flam F, Fisher RA, Ohlsson R (1995) Paternally derived H19 is differentially expressed in malignant and nonmalignant trophoblast. Cancer Res 55:1111–1116.
Steenman MS, Rainier S, Bodry CJ, Grundy P, Horon IL, Feinberg AP (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms’ tumour. Nature Genet 7:433–439.
Ariel I, Lustig O, Oyer CE, Elkin M, Gonik B, Rachmilewitz J, Biran H, Goshen R, de Groot N, Hochberg A (1994) Relaxation of imprinting in trophoblastic disease. Gynecol Oncol 53:212–219.
Acevedo HF, Tong JY, Hartsock RJ (1995) Human chorionic gonadotrophin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 76:1467–1475.
Sand PK, Lurain JR, Brewer JI (1984) Repeat gestational trophoblastic disease. Obstet Gynecol 63:140–144.
Bagshawe KD, Dent J, Webb J (1986) Hydatidiform mole in England and Wales 1973-1983. Lancet 2:673–677.
Federschneider JM, Goldstein DP, Berkowitz RS, Marean AR, Bernstein MR (1980) Natural history of recurrent molar pregnancy. Obstet Gynecol 55:457–459.
Hayashi K, Bracken MB, Freeman DH Jr., Hellenbrand K (1982) Hydatidiform mole in the United States (1970-1977): A statistical and theoretical analysis. Am J Epidemiol 115:67–77.
LaVecchia C, Parazzini F, Decarli A, Franceschi S, Fasoli M, Favalli G, Negri E, Pampallona S (1984) Age of parents and risk of gestational trophoblastic disease. J Natl Cancer Inst 73:639–642.
Yen S, MacMahon B (1968) Epidemiologic features of trophoblastic disease. Am J Obstet Gynecol 101:126–132.
McCorriston CC (1968) Racial incidence of hydatidiform mole. A study in a contained polyracial community. Am J Obstet Gynecol 101:377–382.
LaVecchia C, Franceschi S, Parazzini F, Fasoli M, Decarli A, Gallus G, Tognoni G (1985) Risk factors for gestational trophoblastic disease in Italy. Am J Epidemiol 121:457.
Parazzini F, LaVecchia C, Mangili G, Caminiti C, Negri E, Cecchetti G, Fasoli M (1988) Dietary factors and risk of trophoblastic disease. Am J Obstet Gynecol 158:93–100.
Clement PB, Scully RE (1982) Carcinoma of the cervix: Histologic types. Semin Oncol 9:251–264.
Wright TC, Kurman RJ, Ferenczy A (1994) Carcinoma and other tumors of the cervix. In: Kurman RJ, ed. Blaustein’s Pathology of the Female Genital Tract, 4th ed. New York: Springer-Verlag, pp. 279–326.
Wright TC, Kurman RJ, Ferenczy A (1994) Precancerous lesions of the cervix. In: Kurman RJ, ed. Blaustein’s Pathology of the Female Genital Tract, 4th ed. New York: Springer-Verlag, pp. 229–277.
Jones EG, MacDonald I, Breslow L (1958) A study of epidemiologic factors in carcinoma of the uterine cervix. Am J Obstet Gynecol 76:1–10.
Boyd JT, Doll R (1964) A study of the aetiology of carcinoma of the cervix uteri. Br J Cancer 18:419–434.
Kessler II (1977) Veneral factors in human cervical cancer. Evidence from marital clusters. Cancer 39:1912–1919.
Martin CE II (1967) Marital and coital factors in cervical cancer. Am J Public Health 57:803–814.
Rotkin ID (1967) Adolescent coitus and cervical cancer: Associations of related events with increased risk. Cancer Res 27:603–617.
Terris M, Wilson F, Smith H, Sprung E, Nelson JH Jr. (1967) The relationship of coitus to carcinoma of the cervix. Am J Public Health 57:840–847.
Brinton LA, Tashima KT, Lehman HF, Levine RS, Maliin K, Savitz DA, Stolley PD, Fraumeni JF Jr. (1987) Epidemiology of cervical cancer by cell type. Cancer Res 47:1706–1711.
Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, et al. (1993) Epidemologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85:958–964.
Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P, Tormo MJ, Moreo P, Ascunce N, Gonzalez LC, et al. (1992) Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 52:750–758.
Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJLM, Walboomers JMM (1994) Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 69:114–119.
Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, Manos MM (1991) Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 83:997–1003.
Bernstein A, Harris B (1984) The relationship of dietary and serum vitamin A to the occurrence of cervical intraepithelial neoplasia in sexually active women. Am J Obstet Gynecol 148:309–312.
Marshall JR, Graham S, Byers T, Swanson M, Brasure J (1983) Diet and smoking in the epidemiology of cancer of the cervix. J Natl Cancer Inst 70:847–851.
Vonka V, Kanka J, Roth Z (1987) Herpes simplex type 2 virus and cervical neoplasia. Adv Cancer Res 48:149–191.
Vonka V, Kanka J, Jelinek J, Subrt I, Suchanek A, Havrankova A, Vachal M, Hirsch I, Domorazkova E, Zavadova H, et al. (1984) Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. I. Epidemiological characteristics. Int J Cancer 33:49–60.
Guijon FB, Paraskevas M, Brunham R (1985) The association of sexually transmitted diseases with cervical intraepithelial neoplasia: A case-control study. Am J Obstet Gynecol 151:185–190.
Hildesheim A, Mann V, Brinton LA, Szklo M, Reeves WC, Rawls WE (1991) Herples simplex virus type 2: A possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int J Cancer 49:335–340.
Gagon F Lack of occurrence of cervical carcinoma in nuns. Proceedings of the Second National Cancer Conference Cincinnati, Ohio, March 3-5 1952, 625-638.
Taylor RS, Carroll BE, Lloyd JW (1959) Mortality among women in 3 Catholic religious orders with special reference to cancer. Cancer 12:1207–1223.
Menczer J, Modan B, Oelsner G, Sharon Z, Steintiz R, Sampson S (1978) Adenocarcinoma of the uterine cervix in Jewish women. A distinct epidemiological entity. Cancer 41:2464–2467.
Horowitz IR, Jacobson LP, Zucker PK, Currie JL, Rosenshein NB (1988) Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 31:25–31.
Anton-Culver H, Bloss JD, Bringman D, Lee-Feldstein A, DiSaia P, Manetta A (1992) Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: A population-based epidemiologic study. Am J Obstet Gynecol 166:1507–1514.
Colgan TJ, Auger M, McLaughlin JR (1993) Histopathologic classification of cervical carcinomas and recognition of mucin-secreting squamous carcinomas. Int J Gynecol Pathol 12:64–69.
Schiffman MH, Brinton LA (1995) The epidemiology of cervical carcinogenesis. Cancer 76:1888–1901.
Bender S (1976) Carcinoma in-situ of cervix in sisters. Br Med J 1:502.
Bruinse HW, te Velde ER, de Gast BC (1981) Human leukocyte antigen patterns in a family with cervical cancer. Gynecol Oncol 12:249–252.
Way S, Hetherington J, Galloway DC (1959) Simultaneous cytological diagnosis of cervical cancer in three sisters. Lancet 2:890–891.
Way S (1976) Carcinoma-in-situ of cervix in sisters. Br Med J 1:834.
Andrews FJ, Linehan JJ, Melcher DH (1981) Cervical carcinoma in both mother and daughter. Acta Cytol 25:3–4.
Kullander S (1987) Hereditary factors in human cervical cancer. In: Lynch HT, Kullander S, eds. Cancer Genetics in Women. Boca Raton, FL: CRC Press, pp. 113–121.
Furgyik S, Grubb R, Kullander S, Sandahl B, Wingerup L, Eydal A (1986) Familial occurrence of cervical cancer, Stages O-IV. Acta Obstet Gynecol Scand 65:223–227.
Rotkin ID (1966) Further studies in cervical cancer inheritance. Cancer 19:1251–1268.
Albert S, Child M (1977) Familial cancer in the general population. Cancer 40:1674–1679.
Thompson WD, Schildkraut JM (1991) Family history of gynaecological cancers: Relationships to the incidence of breast cancer prior to age 55. Int J Epidemiol 20:595–602.
Rawls WE, Campione-Piccardo J (1981) Epidemiology of herpes simplex virus type 1 and 2 infections. In: Nahmias AJ, Dowdle WR, Schinazi RF, eds. The Human Herpesviruses. An Interdisciplinary perspective. New York: Elsevier, pp. 137–152.
Naib ZM, Nahmias AJ, Josey WE, Kramer JH (1969) Genital herpetic infection. Association with cervical dysplasia and carcinoma. Cancer 23:940–945.
Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327:1272–1278.
Bosch FX, Manos MM, Munoz N, Sheman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, et al. (1995) Prevalence of human papillomavirus in cervical cancer: A worldwide perspecitve. Natl Cancer Inst 87:796–802.
Campion MJ, McCance DJ, Cuzick J, Singer A (1986) Progressive potential of mild cervical atypia: Prospective cytological, colposcopic, and virological study. Lancet 2:237–240.
DeBritton RC, Hildescheim A, DeLao SL, Brinton LA, Sathya P, Reeves WC (1993) Human papillomaviruses and other influences on survival from cervical cancer in Panama. Obstet Gynecol 81:19–24.
zur Hausen H (1989) Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 49:4677–4681.
Willett GD, Kurman RJ, Reid R, Greenberg M, Jenson AB, Lorincz AT (1989) Correlation of the histologic appearance of intraepithelial neoplasia of the cervix with human papillomavirus types. Emphasis on low grade lesions including so-called flat condyloma. Int J Gynecol Pathol 8:18–25.
Howley PM (1991) Role of the human papillomaviruses in human cancer. Cancer Res 51:5019s–5022s.
Park T, Fujiwara H, Wright TC (1995) Molecular biology of cervical cancer and its precursors. Cancer 76:1902–1913.
Hoppe-Seyler F, Butz K (1994) Cellular control of human papillomavirus oncogene transcription. Mol Carcinogen 10:134–141.
Griep AE, Lambert PF (1994) Role of papillomavirus oncogenes in human cervical cancer: Transgeneic animal studies (43720A). Proc Soc Exp Biol Med 206:24–34.
Scheffner M, Munger K, Byrne JC, Howley PM (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma lines. Proc Natl Acad Sci USA 88:5523–5527.
Hoppe-Seyler F, Butz K (1993) Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J Virol 67:3111–3117.
Durst M, Glitz D, Schneider A, zur Hausen H (1992) Human papillomavirus type 16 (HPV 16) gene expressionn and DNA replication in cervical neoplasia: Analysis by in situ hybridization. Virology 189:132–140.
Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR (1992) Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 23:117–128.
Woodworth CD, Notario V, DiPaolo JA (1990) Transforming growth factors Beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human gential epithelial cells. J Virol 64:4767–4775.
Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrell CJ (1991) Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 338:910–913.
Kaelbling M, Burk RD, Atkin NB, Johnson AB, Klinger HP (1992) Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas. Lancet 340:140–142.
Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T (1992) Alterations of p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 52:5323–5328.
Park DJ, Wilzynski SP, Paquette RL, Miller CW, Koeffler HP (1994) p53 mutations in HPV-negative cervical carcinoma. Oncogene 9:205–210.
Kessis TD, Slebos RJ, Han SM, Shah K, Bosch XF, Munoz N, Hedrick L, Cho KR (1993) p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am J Pathol 143:1398–1405.
Mitra AB, Murty VVVS, Li RG, Pratap M, Luthra UK, Chaganti RSK (1994) Allelotype analysis of cervical carcinoma. Cancer Res 54:4481–4487.
Mitra AB, Murty VVVS, Singh V, Li RG, Pratap M, Sodhani P, Luthra UK, Chaganti RSK (1995) Genetic alterations at 5p15: A potential marker for progression of precancerous lesions of the uterine cervix. J Natl Cancer Inst 87:742–745.
Smits PHM, Smits HL, Jabbink MF, ter Schegget J (1990) The short arm of chromosome 11 likely is involved in the regulation of the human papillomavirus type 16 early enhancer-promotor and in the suppression of the transforming activity of the viral DNA. Virology 176:158–165.
Srivatsan ES, Misra BC, Venugopalan M, Wilczynski SP (1991) Loss of heterozygosity for alleles on chromosome 11 in cervical carcinoma. Am J Hum Genet 49:868–877.
Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle GA (1994) Loss of heterozygosity in cervical carcinoma: Suchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 91:6953–6957.
Keldysh PL, Dragani TA, Fleischman EW, Konstantinova LN, Perevoschikov AG, Pierotti MA, Delia Porta G, Kopnin BP (1993) 11q deletions in human colorectal carcinomas: Cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosom Cancer 6:45–50.
Strickland JE, Tomlinson IPM, Lee ASG, Evans MF, McGee J (1992) Allelic loss on chromosome 11q is a frequent event in breast cancer. Br J Cancer 66(Suppl 17):3.
Tomlinson IPM, Gammack AJ, Strickland JE, Mann GJ, MacKie RM, Kefford RF, McGee J (1993) Loss of heterozygosity in malignant melanoma at loci on chromsomes 11 and 17 implicated in the pathogenesis of other cancers. Genes Chromosom Cancer 7:169–172.
Atkin NB, Baker MC (1979) Chromosome 1 in 26 carcinomas of the cervix uteri. Structural and numerical changes. Cancer 44:604–613.
Atkin NB, Baker MC, Fox MF (1990) Chromosome changes in 43 carcinomas of the cervix uteri. Cancer Genet Cytogenet 44:229–241.
Sreekantaiah C, Bhargava MK, Shetty NJ (1988) Chromosome 1 abnormalities in cervical carcinoma. Cancer 62:1317–1324.
Atkin NB, Baker MC, Ferti-Passantonopoulou A (1983) Chromosome changes in early gynecologic malignancies. Acta Cytol 27:337–341.
Sreekantaiah C, Bhargava MK, Shetty NJ (1987) Cytogenetic findings in two cases of carcinoma in situ of the servix uterus. Gynecol Oncol 28;337–341.
Atkin NB, Baker MC (1982) Nonrandom chromosome changes in carcinoma of the cervix uteri. I. Nine near-diploid tumors. Cancer Genet Cytogenet 7:209–222.
Atkin NB (1986) Chromosome 1 aberrations in cancer. Cancer Gent Cytogenet 21:279–285.
Orth G, Favre M, Breitburd F, et al. (1980) Epidermodysplasia verruciformis: A model for the role of papilloma viruses in human cancer. In: Essex M, Todaro G, Zur Hausen H, eds. Viruses in Naturally Occurring Cancer. Cold Spring Harbor, NX: Cold Spring Harbor Press, pp. 259–282.
Gregoire L, Lawrence WD, Kukuruga D, Eisenbrey AB, Lancaster WD (1994) Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer 57:504–507.
Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM (1994) DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet 6:157–162.
Wank R, Thomssen C (1991) High risk of squamous cell carcinoma of the cervix for women with HLA-DQW3. Nature 352:723–725.
Wank R, Meulen J, Luande J, Eberhardt H, Pawlita M (1993) Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1 0602, 301,0303 alleles. Lancet 341:1215.
Heiland A, Borresen AL, Kaern J, Ronningen KS, Thorsby E (1992) HLA antigens and cervical carcinoma. Nature 356:23.
Glew SS, Duggan-Keen M, Ghosh AK, Ivinson A, Sinnott P, Davidson J, Dyer PA, Stern PL (1993) Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum Immunol 37:157–164.
LaVecchia C, Franceschi S, Decarli A, Gentile A, Fasoli M, Pampallona S, Tognoni G (1984) Dietary vitamin A and the risk of invasive cervical cancer. Int J Cancer 34:319–322.
Peters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE (1986) Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 76:423–428.
Saigo PE, Cain JM, Kim WS, Gaynor JJ, Johnson K, Lewis JDJ (1986) Prognostic factors in adenocarcinoma of the uterine cervix. Cancer 57:1584–1593.
Shorrock K, Johnson J, Johnson IR (1990) Epidemiological changes in cervical carcinoma with particular reference to mucin-secreting subtypes. Histopathology 17:53–57.
Schwartz SM, Weiss NS (1986) Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 124:1045–1047.
Parazzini F, LaVecchia C (1990) Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 39:40–46.
Podczaski E, Kaminski PF, Pees RC, Singapuri K, Sorosky JI (1991) Peutz-Jeghers syndrome with ovarian sex cord tumor with annular tubules and cervical adenoma malignum. Gynecol Oncol 42:74–78.
McGowen L, Young RH, Scully RE (1980) Peutz-Jeghers syndrome with adenoma malignum of the cervix. A report of two cases. Gynecol Oncol 10:125–133.
Kaminski, Norris HJ (1984) Coexistence of ovarian neoplasms and endocervical adenocarcinoma. Obstet Gynecol 64:553–556.
Hurt WG, Silverberg SG, Frable WJ, Belgrad R, Crooks LD Jr. (1977) Adenocarcinoma of the cervix: Histopathologic and clinical features. Am J Obstet Gynecol 129:304–313.
Farnsworth A, Laverty C, Stoler MH (1989) Human papillomavirus messenger RNA expression in adenocarlinoma in situ of the uterine cervix. Int J Gynecol Pathol 8:321–330.
Tase T, Okagaki T, Clark BA, Twiggs LB, Ostrow RS, Faras AJ (1989) Human papillomavirus DNA in adenocarcinoma in situ microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol 8:8–17.
Tase T, Okagaki T, Clark BA, Twiggs LB, Ostrow RS, Faras AJ (1989) Human papillomavirus DNA in glandular dysplasia and microglandular hyperplasia: Presumed precursors of adenocarcinoma of the uterine cervix. Obstet Gynecol 73:1005–1008.
Higgins GD, Phillips GE, Smith LA, Uzelin DM, Burrell CJ (1992) High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasia. Cancer 70:136–146.
Tase T, Okagaki T, Clark BA, Manias DA, Ostrow RS, Twiggs LB, Faras AJ (1988) Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: A study by in situ DNA hybridization. Cancer Res 48:993–998.
Wilczynski SP, Walker J, Liao S, Bergen S, Berman M (1988) Adenocarcinoma of the cervix associated with human papillomavirus. Cancer 62:1331–1336.
Gordon AN, Bornstein J, Kaufman RH, Estrada RG, Adams E, Adler-Storthz K (1989) Human papillomavirus associated with adenocarcinoma and adenoquamous carcinoma of the cervix: Analysis in situ hybridization. Gynecol Oncol 35:345–348.
Menczer J, Yaron-Schiffer O, Leventon-Kriss S, Modan M, Modan B (1981) Herpesvirus type 2 in adenocarcinoma of the uterine cervix: A possible association. Cancer 48:1497–1499.
Lynch HT (1969) Dynamic Genetics Counseling for Clinicians. Springfield, IL: Charles C Thomas.
American Society for Human Genetics, American College of Medical Genetics (1995) Points to consider: Ethical, legal and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 57:1233–1241.
Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall J, Rowley PT (1995) Women’s receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 85:1133–1135.
Lerman C, Schwartz MD, Miller SM, Daly M, Sands C, Rimer BK (1996) A randomized trial of breast cancer risk counseling: Interacting effects of counseling, educational level and coping style. Health Psychol 15:75–83.
Geller G, Bernhardt BA, Helzlsouer K, Holtzman NA, Stefanek M, Wilcox PM (1995) Informed consent and BRCA1 testing. Nature Genet 11:364.
Lerman C, Rimer B, Engstrom P (1991) Cencer risk notification: Psychological and ethical implications. J Clin Oncol 9:1275–1282.
Lerman C, Rimer B, Blumberg B, Christino S, Engstrom PF, MacElwee N, O’Connor K, Sheay J (1990) Effects of coping style and relaxation on cancer chemotherapy side-effects and emotional responses. Cancer Nursing 13:308–315.
Lerman C (1994) Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 154:609–616.
Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, Goldstein L, James J, Engstrom P (1993) Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85:1074–1080.
Cryole RT, Lerman C (1993) Interest in genetic testing and colon cancer susceptibility: Cognitive and emotional correlates. Prev Med 22:284–292.
Daly M, Lerman C (1993) Ovarian cancer risk counseling. Semin Oncol 7:27–34.
Lynch HT, Watson P, Conway TA, Lynch JF, Slominski-Caster SM, Narod SA, Feunteun J, Lenoir G (1993) DNA screening for breast/ovarian cancer susceptibility based on linked markers. Arch Intern Med 153:1979–1987.
Lynch HT, Drouhard T, Vasen HFA, Cavalieri J, Lynch J, Nord S, Smyrk T, Lanspa S, Murphy P, Whelan KL, et al. (1996) Genetic counseling in a Navajo hereditary nonpolyposis colorectal cancer kindred. Cancer 77:30–35.
Andrews LB, Fullerton JE, Holtzman NA, et al. (1994) Assessing Genetic Risk: Implications for Health and Social Policy. Washington DC: National Academy Press.
Regis E (1995) Hacking the mother code. Wired 137 (September).
King RT (1994) Soon a chip will test blood for diseases. The Wall Street Journal (October 25, 1994): B, p.1, New York.
Pokorski RJ (1996) Use of genetic tests to predict and diagnose cancer: An insurance perspective. J Tumor Marker Oncol 11:33–44.
American College of Medical Genetics Storage of Genetics Materials Committee (1995) ACMG Statement. Statement on storage and use of genetic materials. Am J Hum Genet 57:1499–1500.
Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BAJ, Stratton MR, Easton D (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nature Genet 15:103–105.
Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, et al. (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 11:428–433.
Holt JT, Thompson ME, Szabo CI, Robinson-Benion C, Argeaga CL, King M-C, Jensen RA (1996) Growth retardation and tumour inhibition by BRCA1. Nature Genet 12:298–302.
Benkendorf JL, Reutenauer JE, Hughes CA, Eads N, Willison J, Powers M, Lerman C (1997) Patients’ attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. Am J Med Genet 73:296–303.
Lynch HT, Lemon SJ, Durham C, Tinley ST, Connolly C, Lynch J, Surdam J, Orinion E, Slominski-Caster S, Watson P, et al. (1997) A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 79:2219–2228.
Goldberg JM, Piver MS, Jishi MF, Blumenson L (1997) Age at onset of ovarian cancer in women with a strong family history of ovarian cancer. Gynecol Oncol 66:3–9.
Daly MB (1997) Hereditary ovarian cancer: a different disease? Gynecol Oncol 66:1–2
Paterson AD, Kennedy JL, Petronis A (1996) Evidence for genetic anticipation in non-mendelian diseases. Am J Hum Genet 59:264–268.
Sharon SK, Morimatsu M, Albrecht U, Lim D, Regel E, Dinh C, Sands A, Eichele G, Hasty P, Bradley A (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386:804–810.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lynch, H.T., Lemon, S., Lynch, J., Casey, M.J. (1998). Hereditary gynecologic cancer. In: Ozols, R.F. (eds) Gynecologic Oncology. Cancer Treatment and Research, vol 95. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5447-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5447-9_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7487-9
Online ISBN: 978-1-4615-5447-9
eBook Packages: Springer Book Archive